Pfizer: all 4,072 studies
Page 6 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A AdultsActive, not recruitingNCT04370054Phase 3Results posted
- Study of Lorlatinib In People With ALK-positive Non-small Cell Lung CancerCompletedNCT04362072Phase 4Results posted
- Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic DermatitisCompletedNCT04360187Phase 3Results posted
- Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment PatternsCompletedNCT04351334Results posted
- A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic AnemiaCompletedNCT04350606Phase 3Results posted
- Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental OxygenTerminatedNCT04346615Phase 2/3Results posted
- Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT04345367Phase 3Results posted
- A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-WorldCompletedNCT04337138Results posted
- A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLCTerminatedNCT04325698Phase 3Results posted
- Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult ParticipantsTerminatedNCT04323124Phase 1Results posted
- Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)CompletedNCT04321031Phase 2Results posted
- Retrospective Study on Referral Patterns for High Risk Patients Post NephrectomyCompletedNCT04309617Results posted
- Besponsa Post Marketing Surveillance StudyCompletedNCT04307134Results posted
- Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusCompletedNCT04305587Phase 1Results posted
- Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.CompletedNCT04299048Phase 1Results posted
- Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia BCompletedNCT04286412Phase 4Results posted
- Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyActive, not recruitingNCT04281485Phase 3Results posted
- This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.CompletedNCT04267614Results posted
- A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A DayCompletedNCT04267380Results posted
- Renal Impairment Study of PF-06700841CompletedNCT04260464Phase 1Results posted
- A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTSCompletedNCT04258995Phase 2Results posted
- Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCDTerminatedNCT04247594Phase 2Results posted
- Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI ScansCompletedNCT04237792Phase 4Results posted
- Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In ColombiaCompletedNCT04234698Results posted
- A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisCompletedNCT04230213Phase 3Results posted
- A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.TerminatedNCT04225897Phase 2Results posted
- Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell DiseaseTerminatedNCT04218084Phase 3Results posted
- Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple CountriesCompletedNCT04198571Results posted
- A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENTCompletedNCT04193436Phase 1Results posted
- Open-Label Extension of VoxelotorTerminatedNCT04188509Phase 3Results posted
- Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced MalignanciesCompletedNCT04181788Phase 1/2Results posted
- Safety and Efficacy of Trastuzumab BSCompletedNCT04181333Results posted
- Real-world Treatment Patterns and Effectiveness of Palbociclib and AI TherapyCompletedNCT04176354Results posted
- Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) TreatmentsCompletedNCT04175262Results posted
- A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseaseTerminatedNCT04173273Phase 2/3Results posted
- Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.TerminatedNCT04171141Phase 1Results posted
- A Study of Sasanlimab in People With Non-muscle Invasive Bladder CancerActive, not recruitingNCT04165317Phase 3Results posted
- A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT04162769Phase 2Results posted
- Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)CompletedNCT04155541Results posted
- Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.TerminatedNCT04126031Phase 2Results posted
- A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)CompletedNCT04115189Results posted
- Vyndaqel Capsules Special Investigation (ATTR-CM)CompletedNCT04108091Results posted
- A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis SuppurativaCompletedNCT04092452Phase 2Results posted
- Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis DermatitisCompletedNCT04091087Phase 2Results posted
- Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy SubjectsCompletedNCT04091061Phase 1Results posted
- Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis PatientsCompletedNCT04079920Results posted
- Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line SunitinibCompletedNCT04076787Results posted
- Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis PatientsCompletedNCT04071405Results posted
- A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARSCompletedNCT04071158Phase 2Results posted
- Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid TumorsTerminatedNCT04052204Phase 1/2Results posted
- A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis PatientsCompletedNCT04047121Results posted
- Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)TerminatedNCT04043455Phase 2Results posted
- Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial PneumoniaTerminatedNCT04040621Phase 1Results posted
- Precedex Special Investigation (in Pediatric Patients)CompletedNCT04040439Results posted
- A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisCompletedNCT04040192Phase 3Results posted
- A Renal Impairment Study for PF-06651600TerminatedNCT04037865Phase 1Results posted
- Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.CompletedNCT04033991Results posted
- A Study of Ladiratuzumab Vedotin in Advanced Solid TumorsTerminatedNCT04032704Phase 2Results posted
- A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMENCompletedNCT04032093Phase 2Results posted
- Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)CompletedNCT04018001Results posted
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy VolunteersCompletedNCT04016077Phase 1Results posted
- Long-Term PF-06651600 for the Treatment of Alopecia AreataCompletedNCT04006457Phase 3Results posted
- Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative ColitisCompletedNCT03996369Phase 3Results posted
- Changes of Depression After First-year of Tofacitinib in RA PatientsCompletedNCT03992781Results posted
- A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes MellitusCompletedNCT03985293Phase 2Results posted
- IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid ArthritisCompletedNCT03981900Results posted
- Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTXCompletedNCT03975790Results posted
- A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast CancerActive, not recruitingNCT03975647Phase 3Results posted
- Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme BorreliosisCompletedNCT03970733Phase 2Results posted
- A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusCompletedNCT03969719Phase 2Results posted
- Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs BiologicsCompletedNCT03964649Results posted
- A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic ArthritisCompletedNCT03963401Phase 2Results posted
- Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic DermatitisCompletedNCT03954158Phase 2Results posted
- A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell LymphomaTerminatedNCT03947255Phase 2Results posted
- Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisCompletedNCT03945188Phase 3Results posted
- Trial for Treatment Refractory Trigeminal NeuralgiaTerminatedNCT03941834Phase 2Results posted
- Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia BCompletedNCT03938792Phase 3Results posted
- Real-World Observational Study Of Zavicefta to Characterize Use PatternsCompletedNCT03923426Results posted
- UK Ibrance Patient Program (IPP) StudyCompletedNCT03921866Results posted
- Clostridium Difficile Vaccine 2-Dose Versus 3-Dose StudyCompletedNCT03918629Phase 3Results posted
- REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMACompletedNCT03916458Results posted
- An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung CancerCompletedNCT03915951Phase 2Results posted
- Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic DermatitisCompletedNCT03915496Phase 2Results posted
- An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain MetastasisTerminatedNCT03911869Phase 2Results posted
- A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in ChinaCompletedNCT03909971Phase 2Results posted
- LORA-PITA IV General InvestigationCompletedNCT03905798Results posted
- Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic DermatitisCompletedNCT03903822Phase 2Results posted
- A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque PsoriasisCompletedNCT03895372Phase 2Results posted
- Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)CompletedNCT03885089Results posted
- Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)CompletedNCT03885037Results posted
- Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)CompletedNCT03884439Results posted
- Acute Treatment Trial in Adult Subjects With MigrainesCompletedNCT03872453Phase 2/3Results posted
- Evaluate Severe Hepatic Impairment on Dacomitinib PKCompletedNCT03865446Phase 1Results posted
- Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid TumorsCompletedNCT03864042Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia BActive, not recruitingNCT03861273Phase 3Results posted
- A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid TumorsTerminatedNCT03854227Phase 1Results posted
- Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In PsoriasisCompletedNCT03850483Phase 2Results posted
- A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)CompletedNCT03845517Phase 2Results posted
- Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown EtiologyCompletedNCT03842163Results posted
- Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal VaccinationCompletedNCT03835975Phase 3Results posted